You are the profession. Have your say.™

blog posts

  • European experts to work on improving pet cancer diagnosis and treatment with support from Pfizer

    The ACEE group at its first meeting (from left) Malcolm Brearley (ESVONC president and guest), David Argyle (chairman), Johannes Hirschberger, Johan de Vos, Sue Murphy, Paulo Buracco, Laura Blackwood, Frédérique Ponce, Pauline de Fornel and Josep Pastor.

    The Animal Cancer European Expert group has been set up to ‘build and develop best practices in the management of pet cancer'.…

    By: David Watson
    Published: 10 Aug 2009
    0 Comments
  • Experts re-evaluate pain management in canine osteoarthritis

    Canine osteoarthritis experts at the meeting in Paris.

    In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Now it is increasingly apparent that the relationship is far more complex and that pain may be a driver of dise…

    By: David Watson
    Published: 07 Aug 2009
    0 Comments
  • Advances on the US pet osteoarthritis scene

    Chondrocytes.

    US researchers are growing cartilage that can be moulded into permanent joint replacements for dogs; and the Morris Animal Foundation has developed a website aimed at educating pet owners on the early detection and treatment of arthritis in their pets.…

    By: Peter Beaumont
    Published: 06 Aug 2009
    0 Comments
  • West Nile Virus case reported in Italian horse

    WNV is an arthropod-borne virus transmitted by mosquitoes.

    The Italian Government has confirmed the first case of West Nile virus (WNV) in a horse in that country this year. The infected horse is in Correggio, a small town in the northern Italian province of Emilia Romagna.…

    By: David Watson
    Published: 05 Aug 2009
    0 Comments
  • US practices embrace stem cell technology

    Stem cells

    Interest in the clinical use of stem cells has recently increased in private small animal practice in the US, largely on the basis of anecdotal evidence as to its success.…

    By: Peter Beaumont
    Published: 03 Aug 2009
    0 Comments
  • Sanofi-aventis to acquire Merck's interest in Merial

    sanofi aventis logo

    Sanofi-aventis and Merck today announced that the companies have signed a definitive agreement under which Merck will sell its 50% interest in the companies' current animal health joint venture, Merial, to sanofi-aventis for $4 billion in cash.…

    By: David Watson
    Published: 30 Jul 2009
    0 Comments